达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002030 达安基因

等待开盘 01-20 09:30:00

{"stockData":{"symbol":"002030","market":"SZ","secType":"STK","nameCN":"达安基因","latestPrice":6.27,"timestamp":1768872456000,"preClose":6.27,"halted":0,"volume":49700,"delay":0,"changeRate":0,"floatShares":1403000000,"shares":1403000000,"eps":-0.4019,"marketStatus":"等待开盘","change":0,"latestTime":"01-20 09:30:00","open":6.27,"high":6.27,"low":6.27,"amount":311600,"amplitude":0,"askPrice":6.27,"askSize":187,"bidPrice":6.26,"bidSize":60,"shortable":0,"etf":0,"ttmEps":-0.4019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768872600000},"marketStatusCode":7,"adr":0,"adjPreClose":6.27,"symbolType":"stock","openAndCloseTimeList":[[1768872600000,1768879800000],[1768885200000,1768892400000]],"highLimit":6.9,"lowLimit":5.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1403446032,"isCdr":false,"pbRate":1.14,"roa":"--","roe":"--","epsLYR":-0.66,"committee":0.212598,"marketValue":8800000000,"turnoverRate":0,"status":2,"floatMarketCap":8800000000},"requestUrl":"/m/hq/s/002030","defaultTab":"news","newsList":[{"id":"2603093726","title":"达安基因：对赛隽生物1类生物药无强制披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603093726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603093726?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:00","pubTimestamp":1768525256,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，赛隽生物作为公司的合营子公司，是否有法律义务披露其1类生物药披露的相关信息？反而2025年12月31日股东人数应该随年报披露而披露，提前披露年报数据，为什么？公司对广州赛隽生物科技有限公司的1类生物药无强制披露义务。后续如有对此类披露规则的明确要求，公司也会依照执行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600006259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","159839","BK0188","BK0028","BK0046","BK0168","BK0239","BK0042","BK0159","BK0122"],"gpt_icon":0},{"id":"2603251699","title":"达安基因(002030)12月31日股东户数13.2万户，较上期减少2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603251699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603251699?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:26","pubTimestamp":1768382771,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年12月31日公司股东户数为13.2万户，较11月28日减少3000.0户，减幅为2.22%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至12月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年11月28日至2025年12月31日，达安基因区间跌幅为9.28%，在此期间股东户数减少3000.0户，减幅为2.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400029298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","002030","BK0188","BK0168","BK0159","BK0042","BK0239","BK0122"],"gpt_icon":0},{"id":"2603663437","title":"达安基因：赛隽生物未纳入公司合并报表范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2603663437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603663437?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:33","pubTimestamp":1768361586,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：按照公司披露的年报，赛隽生物是公司的合营公司，其近期创新药获批公司不做公告，为什么？达安基因回复：投资者您好，感谢您对达安基因的关注。公司历来披露全资及控股子公司获得三类医疗器械注册证的情况。广州赛隽生物科技有限公司是公司控股子公司广州市达瑞生物技术股份有限公司的合营企业，未纳入公司合并报表范围。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400015726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0188","BK0159","BK0028","BK0168","BK0122","BK0046","BK0042","BK0239"],"gpt_icon":0},{"id":"2601764138","title":"达安基因(002030)12月31日股东户数13.2万户，较上期减少2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601764138","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601764138?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:33","pubTimestamp":1767778403,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年12月31日公司股东户数为13.2万户，较11月28日减少3000.0户，减幅为2.22%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至12月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年11月28日至2025年12月31日，达安基因区间跌幅为9.28%，在此期间股东户数减少3000.0户，减幅为2.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0159","BK0042","BK0028","002030","BK0046","BK0188","BK0239","BK0122"],"gpt_icon":0},{"id":"2593548044","title":"达安基因：截至2025年11月28日股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593548044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593548044?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:48","pubTimestamp":1766450892,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好:请问截止12月19公司日人数是多少，谢谢股东达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年11月28日，公司股东总户数约为13万5千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300006169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0188","BK0159","BK0028","BK0168","BK0122","BK0046","BK0042","BK0239"],"gpt_icon":0},{"id":"2591161248","title":"达安基因(002030)11月28日股东户数13.5万户，较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591161248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591161248?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:44","pubTimestamp":1765791884,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年11月28日公司股东户数为13.5万户，较10月31日减少4000.0户，减幅为2.88%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至11月28日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年10月31日至2025年11月28日，达安基因区间涨幅为0.77%，在此期间股东户数减少4000.0户，减幅为2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0239","BK0188","BK0159","BK0042","002030","BK0046","BK0122"],"gpt_icon":0},{"id":"2590311634","title":"达安基因：公司目前暂无相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311634","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590311634?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:12","pubTimestamp":1765271530,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：当前证监会鼓励上市公司并购，目前公司持有安杰思15%的股份，安杰思每年有近3亿的净利润，如果与之并购，使之财务报表合并对公司将产生积极的效果，请问公司有没有这一方面的考虑？谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注和建议。公司目前暂无相关计划。谢谢！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251209/31853498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002030","BK0159","BK0046","BK0028","BK0042","BK0239","BK0168","BK0188","BK0122"],"gpt_icon":0},{"id":"2588003937","title":"达安基因(002030)11月28日股东户数13.5万户，较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588003937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588003937?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:43","pubTimestamp":1764668612,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年11月28日公司股东户数为13.5万户，较10月31日减少4000.0户，减幅为2.88%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至11月28日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年10月31日至2025年11月28日，达安基因区间涨幅为0.77%，在此期间股东户数减少4000.0户，减幅为2.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200026426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0159","BK0042","BK0122","BK0239","BK0168","BK0188","002030"],"gpt_icon":0},{"id":"1192428920","title":"意大利埃尼公司将尼日利亚深水区OML 118区块股份提升至15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192428920","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192428920?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:18","pubTimestamp":1764058734,"startTime":"0","endTime":"0","summary":"11月25日 - 埃尼公司宣布，从TotalEnergies EP Nigeria Limited收购了额外2.5%的OML 118生产分享合同（PSC）股份，行使其优先购买权。此次交易已获得必要的监管审批，使其在OML 118 PSC的股份从12.5%增加至15%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0046","BK0122","002030","BK0168","BK0188","BK0042","BK0028","BK0159"],"gpt_icon":0},{"id":"2585118725","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118725","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118725?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:27","pubTimestamp":1763713636,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至2025年11月20日，公司的股东人数是多少？谢谢。达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100020190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0122","BK0239","BK0159","BK0042","BK0046","BK0028","002030","BK0168"],"gpt_icon":0},{"id":"2584237636","title":"达安基因最新公告：间接控股股东拟变更为广药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2584237636","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584237636?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:51","pubTimestamp":1763383874,"startTime":"0","endTime":"0","summary":"若本次股权转让和本次协议转让实施完成，广药集团将合计控制公司26.63%股份，进而成为公司的间接控股股东。本次交易若成功实施，不会导致公司控股股东及实际控制人发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700033592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","BK0028","BK0188","BK0042","002030","BK0046","BK0168","BK0159"],"gpt_icon":0},{"id":"2583902580","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2583902580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583902580?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:54","pubTimestamp":1762995256,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好:请问截止11月10日公司股东数量，谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300008146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0239","BK0168","BK0122","BK0188","BK0159","BK0028","BK0042","BK0046"],"gpt_icon":0},{"id":"2582828917","title":"达安基因：开发有甲型乙型流感病毒检测试剂产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2582828917","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582828917?lang=zh_cn&edition=full","pubTime":"2025-11-10 15:54","pubTimestamp":1762761268,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司有没有检测日本最新流感病毒的产品达安基因回复：投资者您好，感谢您对达安基因的关注。公司开发有针对甲型、乙型流感病毒的检测试剂产品，可以适配甲、乙流常规分型的病毒检测需求。公司会持续跟踪流感病毒变异情况，以获取最新检测需求动态。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000017125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0122","BK0188","BK0239","BK0042","BK0046","BK0159","BK0028","BK0168"],"gpt_icon":0},{"id":"2580913783","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580913783","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580913783?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:51","pubTimestamp":1762246267,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：您好：请问10月31日股东人数是多少谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注。截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400025925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0159","BK0042","BK0122","BK0239","BK0168","BK0188","002030"],"gpt_icon":0},{"id":"2579546583","title":"达安基因最新公告：取得一个医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2579546583","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579546583?lang=zh_cn&edition=full","pubTime":"2025-10-31 19:20","pubTimestamp":1761909627,"startTime":"0","endTime":"0","summary":"达安基因公告称，公司近日取得国家药品监督管理局颁发的医疗器械注册证一个，具体为全自动核酸检测分析仪，注册证编号：国械注准20253222122。该医疗器械注册证的取得丰富了公司的产品组合，拓宽了公司产品的应用领域。目前，上述产品尚处于市场开发阶段，市场需求存在不确定性，请广大投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100043708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","002030","BK1222","BK1583","BK0122","BK0159","BK1574","BK0042","BK0188","BK0239","BK0028","BK1100","BK0046","09997","159883","BK0168"],"gpt_icon":0},{"id":"2579148529","title":"图解达安基因三季报：第三季度单季净利润同比增长139.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579148529","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579148529?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:20","pubTimestamp":1761823204,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因2025年三季报显示，前三季度公司主营收入5.04亿元，同比下降14.81%；归母净利润-1.42亿元，同比上升71.85%；扣非净利润-3.25亿元，同比上升24.99%；其中2025年第三季度，公司单季度主营收入1.65亿元，同比下降13.5%；单季度归母净利润4065.64万元，同比上升139.28%；单季度扣非净利润-6016.58万元，同比上升76.32%；负债率12.09%，投资收益-498.76万元，财务费用-2960.96万元，毛利率32.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030"],"gpt_icon":0},{"id":"2579619290","title":"达安基因(002030.SZ)发布前三季度业绩，归母净亏损1.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579619290","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579619290?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:47","pubTimestamp":1761814058,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因(002030.SZ)发布2025年三季度报告，前三季度，公司实现营业收入5.04亿元，同比下降14.81%。归属于上市公司股东净亏损1.42亿元。归属于上市公司股东的扣除非经常性损益净亏损3.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"达安基因(002030.SZ)发布前三季度业绩，归母净亏损1.42亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0188","BK0028","BK0159","002030","BK0046","BK0168","BK0122","BK0239"],"gpt_icon":0},{"id":"2578615788","title":"达安基因：截至2025年9月30日股东总户数约为14万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2578615788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578615788?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:03","pubTimestamp":1761555785,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月20号，公司的股东人数是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年9月30日，公司股东总户数约为14万户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0168","BK0159","BK0239","002030","BK0028","BK0042","BK0122","BK0188"],"gpt_icon":0},{"id":"2577235457","title":"达安基因(002030)9月30日股东户数14万户，较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577235457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577235457?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:10","pubTimestamp":1761124216,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年9月30日公司股东户数为14.0万户，较8月29日减少6000.0户，减幅为4.11%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年8月29日至2025年9月30日，达安基因区间跌幅为5.78%，在此期间股东户数减少6000.0户，减幅为4.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200026720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0239","BK0188","BK0159","BK0042","002030","BK0046","BK0122"],"gpt_icon":0},{"id":"2575237594","title":"达安基因：截至2025年9月30日股东总户数约为14万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2575237594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575237594?lang=zh_cn&edition=full","pubTime":"2025-10-14 08:45","pubTimestamp":1760402713,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止至2025年10月10日收盘公司股东人数为多少，谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年9月30日，公司股东总户数约为14万户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400032250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","BK0188","BK0046","BK0028","BK0168","002030","BK0122","BK0239","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768872465024,"stockEarnings":[{"period":"1week","weight":-0.0218},{"period":"1month","weight":0.0179},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0398},{"period":"1year","weight":0.1157},{"period":"ytd","weight":0.052}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0575},{"period":"3month","weight":0.0505},{"period":"6month","weight":0.1484},{"period":"1year","weight":0.269},{"period":"ytd","weight":0.0366}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州达安基因股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"132000人(较上一季度减少2.22%)","perCapita":"41894股","listingDate":"2004-08-09","address":"广东省广州市黄埔区高新技术开发区科学城香山路19号","registeredCapital":"140344万元","survey":"　　广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是荧光定量PCR系列产品（临床）、化学发光系列、时间分辨系列产品、酶联免疫系列产品、胶体金系列产品、生化系列产品、质谱系列产品、POCT系列产品、仪器与软件类产品、荧光分析系列产品、免疫层析系列产品、微柱凝胶系列产品、荧光原位杂交产品、样本采集系列产品、核酸提取系列产品、检测服务产品、科研服务产品。","listedPrice":7.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达安基因,002030,达安基因股票,达安基因股票老虎,达安基因股票老虎国际,达安基因行情,达安基因股票行情,达安基因股价,达安基因股市,达安基因股票价格,达安基因股票交易,达安基因股票购买,达安基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}